Pharma Mirror

OCTOBER 1, 2020

Since the in-person PACK EXPO International and Healthcare Packaging EXPO have been cancelled, the process and packaging technology specialist Syntegon is presenting its latest solutions at the virtually-hosted PACK EXPO Connects from November 9 to 13, 2020.

Packaging 52

Packaging 52

Pharma Mirror

JULY 31, 2020

Pharmapack Europe (#pharmapackeu), organised by Informa Markets, moves to May 2021 (19-20) to provide attendees, exhibitors and the pharma packaging community the best season and format. The post Pharmapack Moves to May 2021 appeared first on Pharma Mirror Magazine. at Paris Expo, Porte de Versailles. By announcing the rescheduling.

Packaging 52

Packaging 52

Pharma Mirror

JULY 31, 2020

Softbox, a leading global innovator and provider of temperature control packaging systems and thermal covers for the life science and logistics industries, has announced the appointment of Charlie Nicholson as Softbox’s new Global CFO. The post Softbox announces the appointment of new global CFO appeared first on Pharma Mirror Magazine.

Packaging 52

Packaging 52

Pharma Mirror

AUGUST 8, 2020

The post Toppan Subsidiary Okapi Pharmacy Launches Medicine Delivery Service appeared first on Pharma Mirror Magazine. Todokusuri EXPRESS responds to the needs of the.

Packaging 52

Packaging Communication 52

Pharma Mirror

SEPTEMBER 18, 2021

Paris, Ahead of the first Pharmapack Europe to be held in nearly 18-months, Informa has released the results of its global drug delivery and packaging survey, with the USA once again leading ‘drug delivery and device innovation’, but lagging behind all major European nations on sustainability. We are incredibly.

Packaging 52

Packaging 52

Pharma Mirror

NOVEMBER 4, 2022

Terumo is a well-established integrated CDMO in Japan offering end-to-end services for more than 20 years, supporting customers with pre-filled syringe (PFS) design, molding, drug preparation, filling, assembly, and final packaging for challenging biotech drugs and small molecules.

Packaging 52

Packaging 52

Pharma Mirror

SEPTEMBER 16, 2022

Waiblingen/Germany, The Syntegon Group, a globally leadingsupplier of processing and packaging technology, intends to appoint Dr. Peter Hackelas member of the Executive Board at the beginning of 2023. He started his career with McKinsey& Company Inc.

Packaging 52

Packaging 52

Pharma Mirror

SEPTEMBER 27, 2021

New York/USA, At Interphex 2021 in New York, Syntegon (formerly Bosch Packaging Technology) presents new solutions for lab-scale and small batch filling of solid and liquid pharmaceuticals. The post Syntegon to showcase new laboratory and small batch solutions for solid and liquid pharmaceuticals appeared first on Pharma Mirror Magazine.

Packaging 52

Packaging 52

Pharma Mirror

APRIL 13, 2021

Sachets are a popular pharmaceutical and nutraceutical packaging format for consumers and manufacturers alike. The post BENEO presents galenIQ for highly flowable and stable sachet powders appeared first on Pharma Mirror Magazine. Consumers appreciate their ease of use and the ability to take them without water.

Dosage 52

Dosage Packaging 52

Pharma Mirror

FEBRUARY 6, 2024

It has transformed from a “nice-to-have” into a “must-have” part of the evidence package, helping to contextualize clinical research and improve treatment understanding. In recent years, European regulators have supported the The post RWE’s Impact on Product Lifecycle for Biopharma Startups appeared first on Pharma Mirror Magazine.

Packaging 40

Packaging 40

ISPE

OCTOBER 26, 2022

In addition, we took the Board on tours of Vetter’s facilities for sterile products and through all the production steps: compounding to fill-finish to automated visual inspection and secondary packaging. Board members were most impressed by the state-of-the art technology and the use of robots in the processes.

Packaging 52

Packaging Compounding Communication Vaccines 52

ISPE

OCTOBER 27, 2022

As a result, some companies have challenged the paradigm by forgoing lyophilization entirely, opting to provide solution phase API to drug product facilities for filling and packaging. Some regulatory hurdles remain around classification of solution phase oligo as API versus drug product intermediates. Getting More from Facilities.

Process Improvement 98

Process Improvement Packaging Compounding Dosage 98

ISPE

MAY 9, 2023

In addition to the COR, some Latin American markets require approval in the COO, which is defined as the country where the drug is manufactured, packaged, or exported from. Sometimes, COAs for the drug substance, the excipients used in the formulation, and the primary and nonfunctional secondary packaging material are requested.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

ISPE

MARCH 15, 2023

4 The biopharmaceutical industry is taking steps to increase its environmental sustainability, 5 which begins with identifying and testing alternatives to existing procurement, materials, logistics, equipment, services, manufacturing processes, packaging, and facility design 6 (see Table 1). 7 An integrative (vs. 7 An integrative (vs.

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

PharmaShots

MARCH 9, 2023

Other Affiliations: Angela is an active Board of Director member of the Pfizer Foundation (a charitable organization addressing global health challenges), European Federation of Pharmaceutical Industries and Associations (EFPIA), and UPS (the global leader in package delivery and supply chain logistics). LinkedIn Total experience: 31 yrs.

FDA 40

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 40

ISPE

MARCH 29, 2023

The TPP defines the indication and patient population, describes usage of the product, provides dosage and administration details, explains dosage form and strengths, and lists packaging and storage requirements. The purpose of the QTPP is to link the attributes of the DP back through the TPP to the needs of the intended patient population.

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 29, 2023

The TPP defines the indication and patient population, describes usage of the product, provides dosage and administration details, explains dosage form and strengths, and lists packaging and storage requirements. The purpose of the QTPP is to link the attributes of the DP back through the TPP to the needs of the intended patient population.

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 6, 2023

solvent selection, inhaler propellant replacement, and packaging design) to employee travel and commute policy (e.g., recycled content in packaging, reduction of packaging weights). 16 The second category covers the internal business choices that have an influence on scope 3 emissions.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

SEPTEMBER 11, 2023

In a 2009 Pharmaceutical Engineering® magazine article, Mason, McGarvey, and Spearman reported air speed measurements and air flow patterns in conventional cleanrooms with obstacles in the room, which caused obstruction of the unidirectional air flow. x, a free and open-source computational fluid dynamics (CFD) software package.

Documentation 52

Documentation FDA Packaging Communication 52

ISPE

AUGUST 29, 2022

For changes requiring approval before implementation, once the necessary information has been submitted across regions, each health authority must review the data package and documentation based on local requirements. laboratory notebooks, batch records, and technical reports) to submission documents (e.g., Regulatory. Company Name.

Documentation 52

Documentation FDA Communication Packaging 52

ISPE

AUGUST 30, 2022

In this article, the term “raw material” refers to a material used in the manufacturing and packaging of a drug substance (DS) or a drug product (DP). Finally, the DP is packaged in a suitable container to ensure continued quality. This is followed by DP manufacturing, where the DS is formulated with excipients. Company Name.

Documentation 52

Documentation FDA Packaging Communication 52

ISPE

MARCH 7, 2023

Another example might involve developing symbiotic relationships with other companies for them to use what might otherwise be waste (a “circular economy”), e.g., reusing preheated water between neighboring firms or enabling a critical mass of plastic packaging materials to be collected for reprocessing.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

OCTOBER 27, 2022

Different engineering disciplines, such as architectural and process piping, may use different software packages, which can then be combined into a single coordinated model. When it comes to the design of the facility itself, this is almost exclusively now done using three dimensional (3-D) modeling software tools. Accessed 11 August 2022.

Packaging 52

Packaging Communication Immunization Vaccines 52

Pharma Marketing Network

OCTOBER 27, 2020

One is MindMaze now they are unicorn and based in Switzerland and have had over eight thousand patients in 20 Countries and hopefully are coming into the United States later this year what they are doing is virtual reality for stroke and brain injury rehabilitation in fact they treat nine different diseases and disorders using virtual reality right (..)

Hospitals 52

Hospitals Packaging Communication 52

Pharma Marketing Network

OCTOBER 27, 2020

One is MindMaze now they are unicorn and based in Switzerland and have had over eight thousand patients in 20 Countries and hopefully are coming into the United States later this year what they are doing is virtual reality for stroke and brain injury rehabilitation in fact they treat nine different diseases and disorders using virtual reality right (..)

Hospitals 52

Hospitals Packaging Communication 52

ISPE

JANUARY 10, 2023

The strategy is to provide an appropriate characterization package that demonstrates the alternative filter or resin will not impact product quality, submit it in a PAS, and, if needed, submit a request for an expedited review. Four proposed data packages and submission strategies follow.

Packaging 52

Packaging FDA Communication Vaccines 52

ISPE

SEPTEMBER 10, 2023

In these countries, a secondary packaging site change or an active pharmaceutical ingredient (API) manufacturing site addition triggers a new submission equivalent to that required for approval of a generic drug or a line extension, whereas these site changes may be filed as a notification in the US and EU. Commission Regulation (EC) No.

Documentation 98

Documentation Process Improvement Packaging Pharmaceutical Companies 98